All News

Managed care organizations and pharmacy benefit managers are increasingly using strict approaches to manage drugs, including formulary exclusions.

Solanezumab did not significantly affect cognitive decline compared with the placebo in subjects with mild Alzheimer's, but there are still takeaways.

Amgen’s erenumab (Aimovig) achieved positive results in the first-of-its-kind phase 3b LIBERTY trial for the treatment of patients with episodic migraines who had previously failed 2 to 4 preventive treatments.

Patients treated with erenumab had nearly 3-fold higher odds of having their migraine days cut by at least 50%.

Study finds improving adherence to disease-modifying multiple sclerosis medications could reduce clinical relapses while saving on medical costs.

A review found an elevated risk of cancer progression with increasing wait time between positive screening and start of diagnostic testing.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Last year, 41% of pharmacy drug spending was for specialty drugs compared with 59% for traditional drugs.

The drive towards value-based care could accelerate through competition among health plans.

Clinicians who work with adolescents who have asthma report numerous adherence barriers.

Galcanezumab shows a significant reduction in monthly migraine days in treatment-resistant patients.

Tolvaptan is the first drug approved to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease.

How can a pharmacist be prepared for the unexpected?

The much-hailed Mediterranean diet is rich in antioxidants and polyphenols.

Legalizing the sale of syringes creates accessible, affordable, and reliable sources of sterile syringes for injection drug users (IDU).

Pharmacies, and pharmacists across the nation need to be in a constant state of readiness for the next influenza pandemic outbreak.

On her last day of work in the pharmacy, Deborah Maloney went out in a big way.

Cost is a large barrier for taking medications for many patients. So what is one large pharmacy chain looking to do to help the problem?

Pharmacy benefit manager study indicates that moving patients with hemophilia from standard half-life to extended half-life coagulation factor products carries a significant cost increase.

Nivolumab showed major tumor responses in early stage lung cancer patients and an increase in anti-tumor T-cells that remained after the tumor was removed.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

In the health care world, data security has long been a top-of-mind issue.

Brexaolone IV has succeeded in phase 3 trials reducing symptoms of postpartum depression, a condition that affects an average of 11.5% of new mothers each year.

With the growing use of digital patient identification to conduct business it comes as no surprise that many people have sought to take advantage of Medicare members.

For years, organizations have requested that Medicare change Medicare IDs from Social Security numbers, and now they are doing it.

In this competitive job market, we offer advice to help candidates get ahead in the search for a retail pharmacist position.

New treatments for cystic fibrosis, migraines, and multiple sclerosis expected to help push specialty drug costs on the pharmacy benefit to nearly 50% of total drug spending by 2020.

Epidiolex would be the first plant-based cannabinoid approved by the FDA and would create a new category of anti-epileptic drugs.